Cite

Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Intra-nasal vaccination

MLA

Vijaysri, Sangeetha, et al. “Vaccinia Viruses with Mutations in the E3L Gene as Potential Replication-Competent, Attenuated Vaccines: Intra-Nasal Vaccination.” Vaccine, vol. 26, no. 5, Jan. 2008, pp. 664–76. EBSCOhost, https://doi.org/10.1016/j.vaccine.2007.11.045.



APA

Vijaysri, S., Jentarra, G., Heck, M. C., Mercer, A. A., McInnes, C. J., & Jacobs, B. L. (2008). Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Intra-nasal vaccination. Vaccine, 26(5), 664–676. https://doi.org/10.1016/j.vaccine.2007.11.045



Chicago

Vijaysri, Sangeetha, Garilyn Jentarra, Michael C. Heck, Andrew A. Mercer, Colin J. McInnes, and Bertram L. Jacobs. 2008. “Vaccinia Viruses with Mutations in the E3L Gene as Potential Replication-Competent, Attenuated Vaccines: Intra-Nasal Vaccination.” Vaccine 26 (5): 664–76. doi:10.1016/j.vaccine.2007.11.045.